$SPRC Up 196% Premarket! 🚀 🔹 Massive move as subsidiary NeuroThera receives conditional TSX approval for its CliniQuantum acquisition 📈 🔹 Deal gives NeuroTh

$SPRC Up 196% Premarket! 🚀 🔹 Massive move as subsidiary NeuroThera receives conditional TSX approval for its CliniQuantum acquisition 📈 🔹 Deal gives NeuroThera ~54% of CliniQuantum, a quantum-driven clinical trial analytics company ⚛️ 🔹 CliniQuantum uses quantum simulation & Monte Carlo methods…